BEERS REMS, High Alert
Contraindicated in:
Use Cautiously in:
CV: arrhythmias, CARDIAC ARREST
Derm: rash
EENT: blurred vision
Local: phlebitis at IV site, pain at IM site
Neuro: agitation, drowsiness, excess sedation, headache, SUICIDAL THOUGHTS
Resp: APNEA, bronchospasm, cough, LARYNGOSPASM, RESPIRATORY DEPRESSION
Misc:
physical dependence
,psychological dependence
, toleranceDrug-drug:
Use with opioids or other CNS depressants, including other benzodiazepines, nonbenzodiazepine sedative/hypnotics, anxiolytics, general anesthetics, muscle relaxants, antipsychotics, and alcohol, may cause profound sedation, respiratory depression, coma, and death; reserve concurrent use for when alternative treatment options are inadequate.
Drug-Natural Products:
Drug-Food:
Preoperative Sedation/Anxiolysis/Amnesia
Conscious Sedation for Short Procedures
Status Epilepticus
Seizure Clusters
Induction of Anesthesia (Adjunct)
Sedation in Critical Care Settings
Therapeutic Classification: antianxiety agents, anticonvulsants, sedative/hypnotics
Pharmacologic Classification: benzodiazepines
Absorption: Rapidly absorbed following oral and nasal administration; undergoes substantial intestinal and first-pass hepatic metabolism. Well absorbed following IM administration; IV administration results in complete bioavailability.
Distribution: Crosses the blood-brain barrier.
Protein Binding: 97%.
Half-Life: Preterm neonates: 2.617.7 hr; Neonates: 412 hr; Children: 37 hr; Adults: 26 hr (↑ in renal impairment, HF, or cirrhosis).
Caution patient not to stop taking midazolam without consulting health care provider. Abrupt withdrawal may cause sweating, vomiting, muscle cramps, tremors, and seizures; may be life-threatening.
Advise patient that midazolam is a drug with known abuse potential. Protect it from theft, and never give to anyone other than the individual for whom it was prescribed. Store out of sight and reach of children, and in a location not accessible by others.
Advise patient to avoid the use of alcohol or other CNS depressants, including opioids, concurrently with midazolam; may cause respiratory depression and overdose. Instruct patient to consult health care provider before taking Rx, OTC, or herbal products concurrently with this medication.
NDC Code